A new human 95 kDa high density lipoprotein (HDL)-binding protein (HBP) cor
responding to a high affinity HDL-binding site with K-d = 1.67 mug/mL and a
capacity of 13.4 ng/mg was identified in human fetal hepatocytes. The HDL
binding with the 95 kDa HBP plateaus at 2.5-5 mug/mL under reducing and non
reducing conditions. The association of HDL3 with the 95 kDa HBP plateaued
in 15-30 min while dissociation was complete in 30 min. HDL3, apoA-I, and a
poA-II were recognized by the 95 kDa HBP while low density lipoproteins (LD
L) and tetranitromethane-modified HDL were not. The 95 kDa HBP predominantl
y resides on the surface of cells since trypsin treatment of HepG2 cells el
iminated nearly 70% of HDL binding. All studied human cells and cell lines
(HepG2, Caco-2, HeLa, fibroblasts, SKOV-3, PA-I) demonstrated the presence
of the 95 kDa protein. Both RT-PCR and Western blotting for HB-2/ALCAM were
negative in human fetal hepatocytes while Gp96/GRP94 was clearly different
iated from the 95 kDa HBP by two-dimensional electrophoretic mobility. More
over, deglycosylation of HepG2 membrane preparations did not affect either
HDL binding to the 95 kDa HBP or its size, while in contrast it affected th
e molecular weights of HB-2/ALCAM and SR-BI/CLA-1. We conclude that the 95
kDa HBP is a new HDL receptor candidate widely expressed in human cells and
cell lines.